Jeff Yass’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-16,600
Closed -$67K – 12994
2022
Q3
$67K Sell
16,600
-2,200
-12% -$16.7K ﹤0.01% 12013
2022
Q2
$212K Sell
18,800
-18,500
-50% -$222K ﹤0.01% 10491
2022
Q1
$606K Buy
37,300
+30,300
+433% +$776K ﹤0.01% 8459
2021
Q4
$332K Sell
7,000
-22,200
-76% -$1.33M ﹤0.01% 10230
2021
Q3
$2.12M Sell
29,200
-400
-1% -$28.9K ﹤0.01% 5703
2021
Q2
$2.48M Buy
+29,600
New +$1.95M ﹤0.01% 5431

Other funds holding NBP

Jeff Yass's NBP Position: Q3 2026 in Review

Jeff Yass reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 48% in Q3 2026, selling an estimated $24.1K and leaving 14,839 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #13122.

Jeff Yass first reported a position in NBP in Q2 2021 and has held it in 16 quarters since. The position peaked at $922K in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q3 2026.

  • Jeff Yass held 14,839 shares of NovaBridge Biosciences American Depositary Shares worth $20.3K as of Q3 2026.
  • Jeff Yass sold 13,700 NovaBridge Biosciences American Depositary Shares shares in Q3 2026, an estimated $24.1K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13122 holding.
  • Jeff Yass first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 16 quarters since.
  • Jeff Yass's NovaBridge Biosciences American Depositary Shares position peaked at $922K in Q2 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.